Key result
Combined biomarker and Holter model predicts in-hospital STEMI mortality with an AUC of ~0.91.
Why the study?
In-hospital mortality for acute STEMI patients remains high, prompting the development of an early prediction model for in-hospital all-cause death after primary coronary artery stenting.
Can a prediction model combining BNP, CK-MB, BUN, LAC, Holter MHR, and Holter TAB predict in-hospital all-cause death in STEMI patients undergoing primary coronary stenting?
Observational (n=3,916)
No
Can a prediction model combining BNP, CK-MB, BUN, LAC, Holter MHR, and Holter TAB predict in-hospital all-cause death in STEMI patients undergoing primary coronary stenting?
Answers are grounded in this paper and cite their sources.
A novel prediction model incorporating laboratory and Holter monitoring parameters can reliably predict in-hospital mortality risk in STEMI patients after primary stenting.
Background: The in-hospital mortality for acute ST-segment elevation myocardial infarction (STEMI) patients remains high. This study aims to establish an early prediction model for in-hospital all-cause death in patients with STEMI after primary coronary artery stenting. Methods: This retrospective study analyzed 3,916 STEMI patients undergoing primary coronary stenting within 24 h of symptom onset at TEDA International Cardiovascular Hospital (2014-2022). We collected demographic, clinical, and procedural data, along with 48-h laboratory results (including echocardiography and Holter monitoring). The primary outcome was in-hospital all-cause mortality. Eighty clinical parameters were compared between survivors and non-survivors to identify risk factors and develop an early prediction model. Results: In a cohort of 3,916 patients, 54 experienced in-hospital all-cause death. Comparison of 80 clinical variables between groups, followed by univariate logistic regression and least absolute shrinkage and selection operator (LASSO) regression, identified nine risk factors. Multicollinearity analysis confirmed no significant interactions. Multivariate logistic regression revealed six independent predictors: B-type natriuretic peptide (BNP) (per 200 pg/mL), creatine kinase-MB isoenzyme (CK-MB) (per 100 ng/mL), blood urea nitrogen (BUN) (per 1 mmol/L), lactate (LAC) (per 1 mmol/L), Holter mean heart rate (MHR) (per 10 bpm), and Holter total atrial beats (TAB) (per 1,000 times). Receiver operating characteristic (ROC) curve, calibration slope, decision curve analysis (DCA) demonstrated superior net benefit of the combined model over individual predictors. Twenty-five cross-validations confirmed excellent performance of this prediction model, with mean AUC of 0.911 and good stability. Bootstrap internal validation confirmed the good stability (optimism-corrected AUC = 0.873, optimism = 0.019) and calibration (calibration slope = 1.061) of the model, indicating that despite a borderline events per variable (EPV) of 9, the model can reliably predict in-hospital mortality risk in STEMI patients. Conclusion: The combination of BNP, CK-MB, BUN, LAC, Holter MHR, and Holter TAB can effectively predict in-hospital all-cause death in STEMI patients undergoing primary coronary artery stenting, offering potential clinical utility.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) conducted an observational in Acute ST-elevation myocardial infarction (STEMI) (n=3,916). Combined prediction model (BNP, CK-MB, BUN, LAC, Holter MHR, and Holter TAB) vs. Individual predictors was evaluated on In-hospital all-cause mortality (AUC 0.911, 95% CI 0.863-0.959). A combined prediction model incorporating BNP, CK-MB, BUN, lactate, Holter mean heart rate, and Holter total atrial beats effectively predicted in-hospital all-cause mortality in STEMI patients with an AUC of 0.911.
Synapse has enriched 10 related papers. Consider them for comparative context: